0001209191-20-063652.txt : 20201215
0001209191-20-063652.hdr.sgml : 20201215
20201215204442
ACCESSION NUMBER: 0001209191-20-063652
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201211
FILED AS OF DATE: 20201215
DATE AS OF CHANGE: 20201215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jayaraman Vivek K
CENTRAL INDEX KEY: 0001605456
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21937
FILM NUMBER: 201391068
MAIL ADDRESS:
STREET 1: 3910 BRICKWAY BLVD
CITY: SANTA ROSA
STATE: CA
ZIP: 95403
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CERUS CORP
CENTRAL INDEX KEY: 0001020214
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 680262011
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1220 CONCORD AVENUE
STREET 2: SUITE 600
CITY: CONCORD
STATE: CA
ZIP: 94520
BUSINESS PHONE: 9252886000
MAIL ADDRESS:
STREET 1: 1220 CONCORD AVENUE
STREET 2: SUITE 600
CITY: CONCORD
STATE: CA
ZIP: 94520
FORMER COMPANY:
FORMER CONFORMED NAME: CERUS TECHNOLOGIES INC
DATE OF NAME CHANGE: 19960731
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-11
0
0001020214
CERUS CORP
CERS
0001605456
Jayaraman Vivek K
C/O CERUS CORPORATION
1220 CONCORD AVE SUITE 600
CONCORD
CA
94520
0
1
0
0
Chief Commercial Officer
Common Stock
2020-12-11
4
M
0
18895
4.33
A
178898
D
Common Stock
2020-12-11
4
S
0
18895
8.00
D
160003
D
Common Stock
2020-12-11
4
S
0
25000
8.00
D
135003
D
Option (Right to Buy)
4.33
2020-12-11
4
M
0
18895
A
2027-02-28
Common Stock
18895
31105
D
This transaction was executed pursuant to a 10b5-1 plan.
This transaction was executed pursuant to a 10b5-1 plan. The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.01 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter.
Not applicable.
Vivek Jayaraman, by Chrystal Menard, attorney-in-fact
2020-12-15